Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Ovid Therapeutics (OVID) Forecast
NewsEarningsOvid Therapeutics (OVID) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Ovid Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:OVID | Benzinga
Explore Ovid Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OVID.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ovid Therapeutics (OVID) stock?
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Who are Ovid Therapeutics (OVID) competitors?
Other companies in Ovid Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Geovax Labs (NASDAQ:GOVX), GlycoMimetics (NASDAQ:GLYC) and CollPlant Biotechnologies (NASDAQ:CLGN).
What is the forecast, or price target, for Ovid Therapeutics (OVID) stock?
Ovid Therapeutics has a consensus price target of $3.90.
What is the current price for Ovid Therapeutics (OVID)?
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $0.2787 last updated May 23, 2025 at 1:44 PM EDT.
Does Ovid Therapeutics (OVID) pay a dividend?
There are no upcoming dividends for Ovid Therapeutics.
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Ovid Therapeutics (OVID) going to split?
There is no upcoming split for Ovid Therapeutics.
What sector and industry does Ovid Therapeutics (OVID) operate in?
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
